Patients with multiple sclerosis (MS) who were receiving disease-modifying therapies were found to have rare occurrences of severe COVID-19 if they had received the vaccine, according to a study ...
A registry study across 14 Japanese clinics analyzed 179 cases of post-COVID-19 vaccination syndrome (PCVS) and identified ...
New FDA approval language for COVID-19 vaccines is sowing confusion about which conditions put people at greater risk for severe disease and who can avoid the inconvenience and cost of off-label ...
WASHINGTON — The Centers for Disease Control and Prevention’s Immunization Safety Office (ISO) carried out scientifically robust, timely, and effective monitoring and evaluation of vaccine risks ...
Several states have issued their own guidance about COVID-19 vaccines since the FDA released its 2025-2026 formula approvals on Aug. 27, significantly restricting who can access the vaccines for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results